Position in EXEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$493,389
New position
Shares Held
9,068
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#427
of 751 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026ELEVATUS WELATH MANAGEMENT holds $905,144 across 2 Biotechnology names. EXEL ranks #1 (54.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
This page
|
9,068 | $493,389 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
7,196 | $411,755 |
All Filings in EXEL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $493,389 | 9,068 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||